Monsanto, Big Pharma, George Soros, and the Push to Legalize Marijuana

When it comes down to it, corporations have just one purpose: turn a large profit for shareholders. So it should come as no surprise that corporate America has turned its eye toward the wildly successful recreational cannabis movement. In 2015 alone, legal pot sales in the United States jumped 17% to $5.4 billion and are expected to grow 25% this year — an estimated $6.7 billion in U.S. sales. And, of course, corporate interests want their share.

But it’s not simply a modern day gold rush, many feel there is an underlying agenda at hand — with a few very wealthy individuals pulling the strings.

Seeking a medical miracle? Cannabis may hold the answer

Meet Charlotte, a young girl with Dravet syndrome who not so long ago was catatonic and experiencing over 300 seizures per week. Then cannabis entered the picture, and her life changed forever. Down to one seizure each week, Charlotte also began to walk and talk. A feeding tube had been the norm; now she feeds herself unassisted. And this is just one of many miracles attributed to this highly controversial plant.

A beneficial 'weed'

William L. Courtney, M.D. a dietary raw cannabis specialist, makes an important distinction between marijuana and cannabis. When cannabis is juiced or consumed in a raw state, the plant is a potent antioxidant, anti-inflammatory and immune stimulator -- with no psychedelic effect. According to Courtney, marijuana on the other hand is the product of human manipulation by heating the plant, which changes the chemical components of the plant into mind-altering tetrahydrocannabinol (THC). Both forms have their medicinal benefit, although many believe that cannabis in a raw state is the most powerful. Ingesting raw cannabis is effective for pain, epilepsy, depression, anxiety, cancer and autism, as well as a number of different disorders involving dysfunctional immune response, like lupus.